Keywords:
CDKL5 deficiency disorder; burden; caregiver perception; cross-sectional survey; cyclin-dependent kinase-like 5; developmental epileptic encephalopathy; epilepsy; health-related quality of life; online survey; rare disorder
Abstract:
Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) is an ultrarare genetic condition causing developmental epileptic encephalopathy characterized by seizures and motor and intellectual disabilities. No disease-modifying therapies are available, and treatments focus mainly on symptom management to improve quality of life.